Literature DB >> 8686490

Towards an understanding of defense style in terms of temperament and character.

R T Mulder1, P R Joyce, J D Sellman, P F Sullivan, C R Cloninger.   

Abstract

The aim was to investigate the relationships between a model of personality based on the concept of defense mechanisms, as articulated by Vaillant, with the psychobiological model of personality, as developed by Cloninger. A total of 128 adults from 11 family pedigrees with at least two alcohol-dependent members completed the self-report Defense Style Questionnaire and the Temperament and Character Inventory. Immature defenses were largely explained by low character scores, while neurotic defenses were part temperament and part character. Cluster A, B and C defenses were related to low reward dependence, high novelty-seeking and high harm avoidance respectively. In a regression analysis, cluster B and C defenses were more related to low character scores than to temperament but, for cluster A defenses, temperament and character both contributed. The results suggest that it is possible to integrate an ego defense model of personality with a psychobiological model of personality, thereby enriching both approaches.

Entities:  

Mesh:

Year:  1996        PMID: 8686490     DOI: 10.1111/j.1600-0447.1996.tb09809.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  2 in total

1.  Association between PPP1R1B polymorphisms and defense mechanisms in healthy Chinese-Han subjects.

Authors:  Yinglin Huang; Jingying Li; Hui Ma; Xiaofeng Zhao; Yuan Wang; Qiu Jin; Bo Zhang; Lijuan Wu; Huan Ma; Gang Zhu
Journal:  J Mol Neurosci       Date:  2012-10-19       Impact factor: 3.444

2.  Relationships of attention-deficit hyperactivity disorder with defense styles and harm avoidance among male inpatients with alcohol use disorder.

Authors:  Cuneyt Evren; Elvan Cicikci; Gokhan Umut; Bilge Evren; Kubra Durmus
Journal:  Indian J Psychiatry       Date:  2019 Nov-Dec       Impact factor: 1.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.